Evidence map›Paper›PMID 23782552›Full record

ArticleGut microbes

Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity.

Ester Hernández, Rafael Bargiela, María Suárez Diez, Anette Friedrichs, Ana Elena Pérez-Cobas, María José Gosalbes, Henrik Knecht, Mónica Martínez-Martínez, Jana Seifert, Martin von Bergen and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 90 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Dietary prevention of antibiotic-induced dysbiosis and mortality upon aging in mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  6. Review
  7. Article
  8. Review
  9. Microbiota in health and diseases.Signal transduction and targeted therapy · 2022
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. [Research progress on carbohydrate active enzymes of human microbiome].Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2019
    Review
  15. Connection between gut microbiome and the development of obesity.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Review
  16. Stereotypes About Enterotype: the Old and New Ideas.Genomics, proteomics & bioinformatics · 2019
    Review
  17. The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2019
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 7 countries.

Ester HernándezSpanish National Research Council (CSIC), Institute of Catalysis, Madrid, Spain.
Rafael Bargiela
María Suárez Diez
Anette Friedrichs
Ana Elena Pérez-Cobas
María José Gosalbes
Henrik Knecht
Mónica Martínez-Martínez
Jana Seifert
Martin von Bergen
Alejandro Artacho
Alicia Ruiz
Cristina Campoy
Amparo Latorre
Stephan J Ott
Andrés Moya
Antonio Suárez
Vitor A P Martins dos Santos
Manuel Ferrer
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESInstitute of Catalysis and Petrochemistry · RUCentre of Biomedical Research · INClinical Research Center Kiel · DEDeutsches Biomasseforschungszentrum · DEConsejo Superior de Investigaciones Científicas · ESInstitut de Biologie systémique et synthétique · FRUniversidad de Granada · ESUniversitat de València · ESWageningen University & Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The microbiomes in the gastrointestinal tract (GIT) of individuals receiving antibiotics and those in obese subjects undergo compositional shifts, the metabolic effects and linkages of which are not clearly understood. Herein, we set to gain insight into these effects, particularly with regard to carbohydrate metabolism, and to contribute to unravel the underlying mechanisms and consequences for health conditions. We measured the activity level of GIT carbohydrate-active enzymes toward 23 distinct sugars in adults patients (n = 2) receiving 14-d β-lactam therapy and in obese (n = 7) and lean (n = 5) adolescents. We observed that both 14 d antibiotic-treated and obese subjects showed higher and less balanced sugar anabolic capacities, with 40% carbohydrates being preferentially processed as compared with non-treated and lean patients. Metaproteome-wide metabolic reconstructions confirmed that the impaired utilization of sugars propagated throughout the pentose phosphate metabolism, which had adverse consequences for the metabolic status of the GIT microbiota. The results point to an age-independent positive association between GIT glycosidase activity and the body mass index, fasting blood glucose and insulin resistance (r ( 2) ≥ 0.95). Moreover, antibiotics altered the active fraction of enzymes controlling the thickness, composition and consistency of the mucin glycans. Our data and analyses provide biochemical insights into the effects of antibiotic usage on the dynamics of the GIT microbiota and pin-point presumptive links to obesity. The knowledge and the hypotheses generated herein lay a foundation for subsequent, systematic research that will be paramount for the design of "smart" dietary and therapeutic interventions to modulate host-microbe metabolic co-regulation in intestinal homeostasis.

Indexed as

BiotaMicrobiotaObesityAdolescentAdultAgedAnti-Bacterial AgentsBody Mass IndexCarbohydrate MetabolismFemaleGastrointestinal TractHumansHyperglycemiaInsulin ResistanceMaleAnti-Bacterial Agentsantibiotic therapydistal gutglycosidasemetabolic reconstructionobesity

Identifiers

PMID23782552
PMCPMC3744515
OpenAlexW2156002265

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.